Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.
Menniti-Ippolito F, Aiello E, Arzenton E, Assisi A, Blaznik U, Castenmiller JJM, Crevani M, de Clock D, Di Giacomo S, Emendi S, Gonella LA, Ippoliti I, Lindquist M, Magro L, Mazzanti G, Mores N, Moretti U, Moro PA, Novakovic B, Raschi E, Siksna I, Valetto MR, Vitalone A, Vo Van Regnault G. Menniti-Ippolito F, et al. Drug Saf. 2023 May;46(5):435-437. doi: 10.1007/s40264-023-01284-6. Epub 2023 Apr 6. Drug Saf. 2023. PMID: 37022637 No abstract available.
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S; ITA-COVID-19: RAAS inhibitor group. Trifirò G, et al. Drug Saf. 2020 Dec;43(12):1297-1308. doi: 10.1007/s40264-020-00994-5. Drug Saf. 2020. PMID: 32852721 Free PMC article.
Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Morciano C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, Trifirò G, Zanoni G, Puccini A, Sapigni E, Mores N, Leoni O, Monaco G, Clagnan E, Zappetti C, Bovo E, Cutillo M, Da Cas R, Massari M. Morciano C, et al. Among authors: menniti ippolito f. PLoS One. 2024 Jan 19;19(1):e0290879. doi: 10.1371/journal.pone.0290879. eCollection 2024. PLoS One. 2024. PMID: 38241309 Free PMC article.
Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements.
Maggini V, Crescioli G, Ippoliti I, Gallo E, Menniti-Ippolito F, Chiaravalloti A, Mascherini V, Da Cas R, Potenza S, Gritti G, Galiulo MT, Sottosanti L, Vannacci A, Lombardi N, Firenzuoli F. Maggini V, et al. Among authors: menniti ippolito f. J Clin Med. 2023 Jul 17;12(14):4726. doi: 10.3390/jcm12144726. J Clin Med. 2023. PMID: 37510843 Free PMC article.
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.
Crescioli G, Maggini V, Raschi E, Gonella LA, Luxi N, Ippoliti I, Di Giovanni V, Bonaiuti R, Firenzuoli N, Gallo E, Menniti-Ippolito F, Moretti U, Trifirò G, Vannacci A, Firenzuoli F, Lombardi N. Crescioli G, et al. Among authors: menniti ippolito f. Phytother Res. 2023 Nov;37(11):5289-5299. doi: 10.1002/ptr.7960. Epub 2023 Jul 18. Phytother Res. 2023. PMID: 37463655
105 results